Why this fundie is more excited about pet pharma than big pharma
Joanne TranMarkets reporter
Updated
The realisation of how people could often place their pets’ health above their own occurred to fund manager Fleur Wright with the arrival of two dachshunds into her household during the pandemic.
The addition of Frankie and Salami, combined with a professional instinct to hold stocks that “fly a little bit under the radar”, only served to fuel Wright’s conviction around animal pharmaceutical company Zoetis.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles